RecruitingNot applicableNCT07219537
A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
Studying Hereditary nonpolyposis colon cancer
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Massachusetts General Hospital
- Principal Investigator
- Guillermo Tearney, M.D., PhDMassachusetts General Hospital
- Intervention
- Feasibility of using an OCT-based Retrograde Tethered Capsule Endomicroscope device to image the lower GI tract(device)
- Enrollment
- 30 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2023 – 2028
Study locations (1)
- Massachusetts General Hospital, Boston, Massachusetts, United States
Collaborators
The Leona M. and Harry B. Helmsley Charitable Trust · Dana-Farber Cancer Institute
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07219537 on ClinicalTrials.govOther trials for Hereditary nonpolyposis colon cancer
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07163403First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome CarriersFundacion Clinic per a la Recerca Biomédica
- RECRUITINGPHASE1, PHASE2NCT06898450A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.Nimbus Wadjet, Inc.
- RECRUITINGNANCT05963191CAD-EYE System for the Detection of Neoplastic Lesions in Patients With Lynch SyndromePERROD Guillaume
- RECRUITINGNCT06708429Lynch Syndrome X-Talk of Enteral Mucosa With Immune SystemSan Raffaele University
- ACTIVE NOT RECRUITINGPHASE2NCT05419011Testing a Combination of Vaccines for Cancer Prevention in Lynch SyndromeNational Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGPHASE1NCT05078866Cancer Preventive Vaccine Nous-209 for Lynch Syndrome PatientsNational Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGPHASE3NCT02813824Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch SyndromeAssistance Publique - Hôpitaux de Paris
- ACTIVE NOT RECRUITINGNCT02371135Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis SyndromesMemorial Sloan Kettering Cancer Center